We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

260 hedge funds and large institutions have $3.09B invested in Axsome Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 26

28% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 75

7% more funds holding

Funds holding: 244 → 260 (+16)

1% less capital invested

Capital invested by funds: $3.12B → $3.09B (-$30.4M)

1.03% less ownership

Funds ownership: 82.88% → 81.84% (-1%)

25% less call options, than puts

Call options by funds: $49.5M | Put options by funds: $66.4M

31% less funds holding in top 10

Funds holding in top 10: 13 → 9 (-4)

Holders
260
Holders Change
+16
Holders Change %
+6.56%
% of All Funds
3.75%
Holding in Top 10
9
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-30.77%
% of All Funds
0.13%
New
45
Increased
96
Reduced
75
Closed
26
Calls
$49.5M
Puts
$66.4M
Net Calls
-$16.9M
Net Calls Change
-$54.8M

Top Buyers

1
Macquarie Group
Macquarie Group
Australia
+$56.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$36.7M
3
DTC
Deep Track Capital
Connecticut
+$25.6M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$23.5M
5
EAM
Eagle Asset Management
Florida
+$19M

Top Sellers

1
BI
BVF Inc
California
-$158M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.5M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$29.1M
4
TCM
Tang Capital Management
California
-$25.5M
5
Morgan Stanley
Morgan Stanley
New York
-$24.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
251
American Capital Advisory
Idaho
$1.23K +$1.68K +20 New
AWM
252
Atticus Wealth Management
Florida
$1.2K – – –
NSIM
253
North Star Investment Management
Illinois
$1.04K – – –
VNA
254
Valley National Advisers
Pennsylvania
$1K – – –
IGWM
255
ICA Group Wealth Management
Colorado
$798 +$839 +10 New
FFA
256
Farther Finance Advisors
California
$770 -$84 -1 -9%
IFAM
257
Institutional & Family Asset Management
Colorado
$399 +$420 +5 New
RIL
258
Rothschild Investment LLC
Illinois
$399 +$420 +5 New
FGAM
259
Financial Gravity Asset Management
Texas
$306 +$336 +4 New
PS
260
Principal Securities
Iowa
$239 – – –
BI
261
BVF Inc
California
– -$158M -1,981,100 Closed
TCM
262
Tang Capital Management
California
– -$25.5M -320,000 Closed
ABG
263
Ally Bridge Group
New York
– -$8.03M -100,862 Closed
LIP
264
Lighthouse Investment Partners
Florida
– -$4.47M -56,202 Closed
MWM
265
Meridian Wealth Management
Kentucky
– -$1.63M -20,498 Closed
CM
266
Caption Management
Oklahoma
– -$1.48M -17,600 Closed
TD Asset Management
267
TD Asset Management
Ontario, Canada
– -$1.27M -16,000 Closed
PAMP
268
Polar Asset Management Partners
Ontario, Canada
– -$1.23M -15,465 Closed
Connor, Clark & Lunn Investment Management (CC&L)
269
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.14M -14,339 Closed
ACM
270
Aquatic Capital Management
Illinois
– -$1.12M -14,100 Closed
YIH
271
Y-Intercept (HK)
Hong Kong
– -$898K -11,285 Closed
QIM
272
Quantitative Investment Management
Virginia
– -$806K -10,138 Closed
HF
273
HRT Financial
New York
– -$738K -9,279 Closed
SSA
274
Sierra Summit Advisors
Nevada
– -$734K -9,224 Closed
FC
275
FORA Capital
Florida
– -$709K -8,907 Closed
8 9 10
11
12

AXSM Hedge Fund Activity: Q1 2024 in Review

260 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q1 2024, worth a combined $3.09B — down 0.98% from $3.12B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new AXSM positions and 26 closed out — a net gain of 19 holders — while 96 added to existing stakes and 75 trimmed.

The largest buyer was Macquarie Group, adding an estimated $56.5M. The largest seller was BVF Inc, exiting entirely with an estimated $158M sold.

  • 260 institutional investors held Axsome Therapeutics (AXSM) as of Q1 2024, up from 244 in Q4 2023.
  • Funds reported $3.09B of Axsome Therapeutics stock for Q1 2024, down 0.98% quarter-over-quarter.
  • 45 funds opened new Axsome Therapeutics positions in Q1 2024 and 26 closed out, a net change of +19 holders.
  • The largest Axsome Therapeutics buyer in Q1 2024 was Macquarie Group, an estimated $56.5M added.
  • The largest Axsome Therapeutics seller in Q1 2024 was BVF Inc, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2024.